WASSERFALL; Clive Henry
Patent Applications and Registrations
Patent applications and USPTO patent grants for WASSERFALL; Clive Henry.The latest application filed is for "materials and methods for modulating immune responses".
- WASSERFALL; Clive Henry - Gainesville FL
| Patent | Date |
|---|---|
| Materials And Methods For Modulating Immune Responses App 20180311344 - WASSERFALL; Clive Henry ; et al. | 2018-11-01 |
| Materials and methods for modulating immune responses Grant 10,022,440 - Wasserfall , et al. July 17, 2 | 2018-07-17 |
| Materials and Methods for Modulating immune Responses App 20150147388 - Wasserfall; Clive Henry ; et al. | 2015-05-28 |
| Antigen-specific, Tolerance-inducing Microparticles And Uses Thereof App 20130287729 - Keselowsky; Benjamin George ; et al. | 2013-10-31 |
| Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease App 20100178652 - Litherland; Sally A. ; et al. | 2010-07-15 |
| Materials and Methods for Reversing Type-1 Diabetes App 20090162345 - Atkinson; Mark A. ; et al. | 2009-06-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 